FDA Inspection
Raed Al-RajabiRaed Al-Rajabi – FDA Inspection, Mar 27, 2026
Record Details
This FDA Inspection record concerns Raed Al-Rajabi, with an inspection on March 27, 2026, issued by the Kansas City District Office, covering human drugs.
View Company Profile
ID · c3215eb6-f6bd-4c45-b25e-26c447aaaeaa
Inspection Facts
- Inspection number
- 1309920
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Raed Al-Rajabi
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 7, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Raed Al-Rajabi
- FDA Inspection 1119599 - 2020-02-07
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.